ExamPat

Magnolia Medical Technologies

Patent owner in reexamination·6 ex parte reexams

Magnolia Medical Technologies's patents have been the subject of 6 USPTO ex parte reexaminations, with 2 currently open. Its patents are most often challenged by Kurin, Inc.. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.

Filings by year

2
24
4
25

Top requesters

Outcome track record

How reexams of this owner's patents resolve: claims confirmed, amended, mixed, or fully canceled.

  • Certificate outcome split across every bucket
  • Claim-survival rate

Defense metrics

Claim-survival rate, average pendency, and the open/closed split across every reexam of this owner's patents.

  • Survival rate of closed proceedings
  • Average pendency in months

Challengers & examiners

Which requesters most often challenge this owner's patents, and which examiners decide them.

  • Top requesters
  • Most frequent examiners

Recent reexaminations (6)

Control #FiledPatentTitleRequesterStatus
90/015,399Jul 21, 202510,039,483FLUID DIVERSION MECHANISM FOR BODILY-FLUID SAMPLING—Open
90/019,825Jan 21, 202511,653,863FLUID CONTROL DEVICES AND METHODS OF USING THE SAMEKurin, Inc.Closed
90/019,824Jan 21, 202511,903,709FLUID CONTROL DEVICES AND METHODS OF USING THE SAMEKurin, Inc.Closed
90/019,823Jan 21, 202511,529,081FLUID CONTROL DEVICES AND METHODS OF USING THE SAMEKurin, Inc.Open
90/019,757Dec 6, 20249,855,002SYSTEMS AND METHODS FOR PARENTERALLY PROCURING BODILY-FLUID SAMPLES WITH REDUCED CONTAMINATIONKurin, Inc.Closed
90/019,756Dec 6, 202410,052,053SYSTEMS AND METHODS FOR PARENTERALLY PROCURING BODILY-FLUID SAMPLES WITH REDUCED CONTAMINATIONKurin, Inc.Closed

Other patent owners

See the full reexam picture for Magnolia Medical Technologies

Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.